))
Episode 4. GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on August 08, 2024 13:04 (
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 412867664 series 3564652
Content provided by Micaela Hayes, PharmD & Morgan Grier, PharmD, Micaela Hayes, and Morgan Grier. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Micaela Hayes, PharmD & Morgan Grier, PharmD, Micaela Hayes, and Morgan Grier or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of the Pharm So Hard Podcast, the hosts discuss GLP-1 receptor agonists, a class of medications used to manage blood sugar levels in patients with type 2 diabetes and to treat obesity. They provide an overview of the history and development of GLP-1 receptor agonists, highlighting their clinical superiority and various benefits. The hosts also explain the role of GLP-1s in the body, including their glucose-dependent insulin secretion and effects on gastric emptying. They discuss the impact of GLP-1s on hunger and mental health, emphasizing the reduction of food noise and improvement in satiety levels. Additionally, they differentiate GLP-1 receptor agonists for diabetes and weight loss and explore their indications and guideline positioning.
Takeaways
GLP-1 receptor agonists are a class of medications used to manage blood sugar levels in patients with type 2 diabetes and to treat obesity.
GLP-1 receptor agonists have shown clinical superiority to other anti-hyperglycemic drugs, improving glycemic control, reducing weight loss and blood pressure, and providing cardio-protective benefits.
GLP-1s increase glucose-dependent insulin secretion, block glucagon secretion, and slow gastric emptying, leading to improved blood sugar control and increased satiety.
GLP-1 receptor agonists have a positive impact on mental health, reducing food noise and helping individuals make healthier food choices.
Different GLP-1 receptor agonists have specific indications for diabetes and weight loss, and their use is guided by clinical guidelines.
GLP-1 receptor agonists are FDA-approved for improving glycemic control in patients with type 2 diabetes and for the treatment of obesity.
The choice of GLP-1 receptor agonist depends on factors such as comorbidities, weight loss goals, and patient preferences.
GLP-1 receptor agonists have different dosing regimens, and the specific dose may vary based on the indication and the product.
Common side effects of GLP-1 receptor agonists include nausea, vomiting, and diarrhea, but these side effects often improve with continued use and proper management. GLP-1 agonists can cause loss of appetite as a side effect.
GLP-1s are being used off-label for conditions such as NAFLD and depression.
GLP-1s may have positive effects on bone health and blood pressure.
The high cost of GLP-1s poses challenges for patient access.
8 episodes
Share
